Xue (Shelly) Li
About Xue (Shelly) Li
Xue (Shelly) Li is the Associate Director and Group Leader at Bristol-Myers Squibb, with over 10 years of experience in multinational biotech and pharmaceutical companies.
Current Position at Bristol-Myers Squibb
Xue (Shelly) Li is currently serving as an Associate Director and Group Leader at Bristol-Myers Squibb in New Brunswick, New Jersey, United States. In her role, she oversees analytical programs that support the advancement of analytical control strategies across clinical development, commercial development, and regulatory filing. She has led the development of innovative technology strategies such as LC-MS based identification strategy and AQbD-guided method development strategy.
Previous Roles at Novartis Pharmaceuticals Corporation
From 2012 to 2017, Xue (Shelly) Li worked at Novartis Pharmaceuticals Corporation in the San Francisco Bay Area. During her tenure, she held various positions including Fellow, Principal Scientist, and Senior Scientist. In these roles, she contributed to multiple projects and harnessed her expertise to drive scientific advancements in the field.
Experience at Amgen
Between 2007 and 2010, Xue (Shelly) Li served as a Scientist at Amgen in the Greater Denver Area. In this role, she gained valuable experience in the biopharmaceutical industry, focusing on analytical methods and supporting various research and development initiatives.
Postdoctoral Research at Harvard Medical School
Xue (Shelly) Li spent two years, from 2005 to 2007, as a Postdoctoral Research Fellow at Harvard Medical School in the Greater Boston Area. During this period, she conducted advanced research which laid the foundation for her future contributions in the biotech and pharmaceutical sectors.
Educational Background and Expertise
Xue (Shelly) Li holds a Ph.D. in Bioanalytical Chemistry from Michigan State University, which she obtained between 2001 and 2005. She also earned a Bachelor's degree in Chemistry from Tsinghua University, graduating in 2000. Her comprehensive technical background spans both small and large molecule analysis, and she is skilled in modern analytical techniques such as mass spectrometry, chromatography, and electrophoresis. She has over 10 years of experience in multinational biotech/pharmaceutical companies and specializes in analytical method design, development, validation, and transfer.